214 related articles for article (PubMed ID: 17003232)
1. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Chu G; Jia R; Yang D
J Nephrol; 2006; 19(3):286-95. PubMed ID: 16874687
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational activation of endothelial nitric oxide synthase attenuates carbon tetrachloride-induced hepatotoxicity in newborn rats.
Liu H; Subramony C; Nowicki M
Pediatr Res; 2008 Jun; 63(6):613-9. PubMed ID: 18317400
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
[TBL] [Abstract][Full Text] [Related]
6. Tannin 1-alpha-O-galloylpunicalagin induces the calcium-dependent activation of endothelial nitric-oxide synthase via the phosphatidylinositol 3-kinase/Akt pathway in endothelial cells.
Chen LG; Liu YC; Hsieh CW; Liao BC; Wung BS
Mol Nutr Food Res; 2008 Oct; 52(10):1162-71. PubMed ID: 18435486
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C.
Wagner L; Laczy B; Tamaskó M; Mazák I; Markó L; Molnár GA; Wagner Z; Mohás M; Cseh J; Fekete A; Wittmann I
Endothelium; 2007; 14(4-5):245-55. PubMed ID: 17922342
[TBL] [Abstract][Full Text] [Related]
8. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
9. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of eNOS.
Anselm E; Chataigneau M; Ndiaye M; Chataigneau T; Schini-Kerth VB
Cardiovasc Res; 2007 Jan; 73(2):404-13. PubMed ID: 16962569
[TBL] [Abstract][Full Text] [Related]
10. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein.
Papapetropoulos A; Fulton D; Lin MI; Fontana J; McCabe TJ; Zoellner S; García-Cardeña G; Zhou Z; Gratton JP; Sessa WC
Mol Pharmacol; 2004 Feb; 65(2):407-15. PubMed ID: 14742683
[TBL] [Abstract][Full Text] [Related]
11. Young environment reverses the declined activity of aged rat-derived endothelial progenitor cells: involvement of the phosphatidylinositol 3-kinase/Akt signaling pathway.
Zhu G; Song M; Wang H; Zhao G; Yu Z; Yin Y; Zhao X; Huang L
Ann Vasc Surg; 2009; 23(4):519-34. PubMed ID: 19540437
[TBL] [Abstract][Full Text] [Related]
12. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin.
Xi W; Satoh H; Kase H; Suzuki K; Hattori Y
Biochem Biophys Res Commun; 2005 Jun; 332(1):200-5. PubMed ID: 15896318
[TBL] [Abstract][Full Text] [Related]
13. Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress.
Dixit M; Loot AE; Mohamed A; Fisslthaler B; Boulanger CM; Ceacareanu B; Hassid A; Busse R; Fleming I
Circ Res; 2005 Dec; 97(12):1236-44. PubMed ID: 16284184
[TBL] [Abstract][Full Text] [Related]
14. Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.
Li R; Zhang H; Wang W; Wang X; Huang Y; Huang C; Gao F
Eur J Pharmacol; 2010 Feb; 628(1-3):140-7. PubMed ID: 19944677
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H
Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883
[TBL] [Abstract][Full Text] [Related]
16. Renal activity of Akt kinase in obese Zucker rats.
Zdychová J; Kazdová L; Pelikanová T; Lindsley JN; Anderson S; Komers R
Exp Biol Med (Maywood); 2008 Oct; 233(10):1231-41. PubMed ID: 18641049
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
Mueck AO; Seeger H; Wallwiener D
Exp Clin Endocrinol Diabetes; 2001; 109(3):181-3. PubMed ID: 11409302
[TBL] [Abstract][Full Text] [Related]
18. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta.
Toba H; Gomyo E; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Asayama J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2006; 33(5-6):440-7. PubMed ID: 16700876
[TBL] [Abstract][Full Text] [Related]
20. Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.
Jojima T; Suzuki K; Hirama N; Uchida K; Hattori Y
Diabetes Obes Metab; 2009 Feb; 11(2):143-9. PubMed ID: 18564176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
